Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
M1 Medulloblastoma: high risk at any age.
Sanders RP, Onar A, Boyett JM, Broniscer A, Morris EB, Qaddoumi I, Armstrong GT, Boop FA, Sanford RA, Kun LE, Merchant TE, Gajjar A. Sanders RP, et al. Among authors: qaddoumi i. J Neurooncol. 2008 Dec;90(3):351-5. doi: 10.1007/s11060-008-9671-9. Epub 2008 Aug 15. J Neurooncol. 2008. PMID: 18704266 Free PMC article.
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S, Pollack IF, Goldman S, Doyle LA, Stewart CF, Boyett JM, Kun LE, Fouladi M. Banerjee A, et al. Among authors: qaddoumi i. Neuro Oncol. 2017 Aug 1;19(8):1135-1144. doi: 10.1093/neuonc/now282. Neuro Oncol. 2017. PMID: 28339824 Free PMC article. Clinical Trial.
Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion.
Chiang J, Dalton J, Upadhyaya SA, Patay Z, Qaddoumi I, Li X, Segura AD, Sharma S, Ismail A, Shurtleff SA, Raimondi SC. Chiang J, et al. Among authors: qaddoumi i. Acta Neuropathol. 2019 Jan;137(1):179-181. doi: 10.1007/s00401-018-1940-x. Epub 2018 Nov 21. Acta Neuropathol. 2019. PMID: 30465258 No abstract available.
Neuropsychological outcomes of patients with low-grade glioma diagnosed during the first year of life.
Heitzer AM, Ashford JM, Hastings C, Liu APY, Wu S, Bass JK, Vestal R, Hoehn M, Chiang J, Ghazwani Y, Acharya S, Boop F, Gajjar A, Merchant TE, Qaddoumi I, Conklin HM. Heitzer AM, et al. Among authors: qaddoumi i. J Neurooncol. 2019 Jan;141(2):413-420. doi: 10.1007/s11060-018-03048-0. Epub 2018 Nov 22. J Neurooncol. 2019. PMID: 30467811 Free PMC article.
Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
Liu APY, Hastings C, Wu S, Bass JK, Heitzer AM, Ashford J, Vestal R, Hoehn ME, Ghazwani Y, Acharya S, Conklin HM, Boop F, Merchant TE, Gajjar A, Qaddoumi I. Liu APY, et al. Among authors: qaddoumi i. Cancer. 2019 Apr 1;125(7):1163-1175. doi: 10.1002/cncr.31918. Epub 2019 Jan 8. Cancer. 2019. PMID: 30620400 Free PMC article.
171 results